Biotage Ab Stock Operating Margin
BITGF Stock | USD 16.87 0.00 0.00% |
Biotage AB fundamentals help investors to digest information that contributes to Biotage AB's financial success or failures. It also enables traders to predict the movement of Biotage OTC Stock. The fundamental analysis module provides a way to measure Biotage AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotage AB otc stock.
Biotage |
Biotage AB OTC Stock Operating Margin Analysis
Biotage AB's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Based on the recorded statements, Biotage AB has an Operating Margin of 0.0%. This is 100.0% lower than that of the sector and 100.0% lower than that of the Operating Margin industry. The operating margin for all United States stocks is 100.0% lower than that of the firm.
Biotage Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotage AB's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Biotage AB could also be used in its relative valuation, which is a method of valuing Biotage AB by comparing valuation metrics of similar companies.Biotage AB is currently under evaluation in operating margin category among related companies.
Biotage Fundamentals
Return On Equity | 0.18 | |||
Return On Asset | 0.11 | |||
Profit Margin | 0.16 % | |||
Current Valuation | 1.17 B | |||
Shares Outstanding | 65.98 M | |||
Shares Owned By Insiders | 0.58 % | |||
Shares Owned By Institutions | 64.57 % | |||
Price To Earning | 47.58 X | |||
Price To Book | 6.36 X | |||
Price To Sales | 6.61 X | |||
Revenue | 1.23 B | |||
Gross Profit | 755 M | |||
EBITDA | 347 M | |||
Net Income | 205 M | |||
Cash And Equivalents | 15.1 M | |||
Cash Per Share | 0.23 X | |||
Total Debt | 150 M | |||
Debt To Equity | 0.16 % | |||
Current Ratio | 2.43 X | |||
Book Value Per Share | 1.17 X | |||
Cash Flow From Operations | 353 M | |||
Earnings Per Share | 0.35 X | |||
Number Of Employees | 510 | |||
Beta | 0.81 | |||
Market Capitalization | 1.12 B | |||
Total Asset | 1.99 B | |||
Retained Earnings | 541 M | |||
Working Capital | 212 M | |||
Current Asset | 327 M | |||
Current Liabilities | 115 M | |||
Z Score | 4.2 | |||
Annual Yield | 0.01 % | |||
Net Asset | 1.99 B |
About Biotage AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotage AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotage AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotage AB based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biotage AB in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biotage AB's short interest history, or implied volatility extrapolated from Biotage AB options trading.
Pair Trading with Biotage AB
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotage AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotage AB will appreciate offsetting losses from the drop in the long position's value.Moving together with Biotage OTC Stock
0.74 | GOOG | Alphabet Class C Aggressive Push | PairCorr |
0.64 | AMZN | Amazon Inc Earnings Call This Week | PairCorr |
Moving against Biotage OTC Stock
0.83 | MCD | McDonalds Earnings Call This Week | PairCorr |
0.74 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
0.74 | BA | Boeing Financial Report 24th of July 2024 | PairCorr |
0.71 | INTC | Intel Earnings Call Tomorrow | PairCorr |
0.64 | AAPL | Apple Inc Earnings Call Next Week | PairCorr |
The ability to find closely correlated positions to Biotage AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotage AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotage AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotage AB to buy it.
The correlation of Biotage AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotage AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotage AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotage AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotage AB. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Biotage OTC Stock analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Transaction History View history of all your transactions and understand their impact on performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |